Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Treasury Shares (2016 - 2018)

BeOne Medicines (BEIGF) has disclosed Treasury Shares for 4 consecutive years, with $14.1 million as the latest value for Q4 2018.

  • Quarterly Treasury Shares rose 859.71% to $14.1 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $14.1 million through Dec 2018, up 859.71% year-over-year, with the annual reading at $14.1 million for FY2018, 1649.14% up from the prior year.
  • Treasury Shares for Q4 2018 was $14.1 million at BeOne Medicines, up from $527904.0 in the prior quarter.
  • The five-year high for Treasury Shares was $14.1 million in Q4 2018, with the low at $44445.0 in Q4 2015.
  • Average Treasury Shares over 4 years is $3.2 million, with a median of $1.2 million recorded in 2017.
  • The sharpest move saw Treasury Shares skyrocketed 2318.72% in 2016, then skyrocketed 36.69% in 2017.
  • Over 4 years, Treasury Shares stood at $44445.0 in 2015, then surged by 2318.72% to $1.1 million in 2016, then surged by 36.69% to $1.5 million in 2017, then surged by 859.71% to $14.1 million in 2018.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $14.1 million, $527904.0, and $4.1 million for Q4 2018, Q2 2018, and Q1 2018 respectively.